COVID-19 Deaths on the Decline in Patients With Cancer
Registry data show significant decreases in 14-day and 3-month case-fatality rates.
All articles by Jon Kelvey
EGFR Positivity May Be Poor Predictor of Recurrence in Non-Small Cell Lung Cancer
Despite high rates of recurrence, 37% of patients with stage IB-IIIA NSCLC remained disease-free at 5 years.
Adding Ibrutinib to R-CHOP Doubles EFS in 2 Subgroups of Diffuse Large B-Cell Lymphoma
Younger patients with the MCD and N1 subtypes of DLBCL had 3-year event-free survival rates of 100% when they received ibrutinib plus R-CHOP.
Racial/Ethnic Disparities in MRI Use May Affect Prostate Cancer Diagnosis
Asian, Black, and Hispanic patients were all less likely than White patients to undergo a prostate MRI.
Factors That Impact HRQOL in Pediatric Patients With Chronic Myeloid Leukemia
Patients’ age, sex, and treatment-related symptoms, as well as mothers’ education level, were significantly associated with HRQOL.
Immune Checkpoint Inhibitors May Not Benefit Trial-Ineligible Cancer Patients
The restricted mean survival times were similar at 12 months and 36 months.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse
More than one-third of tumors sequenced carried a high mutation burden.
Metformin Fails to Show Benefit in Non-Small Cell Lung Cancer Trials
Metformin did not improve progression-free or overall survival in either study.
Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer
The study showed differences by cancer type and race/ethnicity.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...